Cardiogeni PLC - Accounts Publication Update
Announcement provided by
Cardiogeni Plc · CGNI28/10/2026 07:00
28 October 2026
Cardiogeni PLC
(“Cardiogeni” or the “Company”)
Update on timing of publication of audited annual accounts
Cardiogeni (AQSE: CGNI), a
The Company announced on 1 October 2026 that the release of its accounts would be delayed beyond 30 September 2026, the original deadline, and that trading in its shares would be temporarily suspended as a result.
The Company has been working closely with its auditors to get the accounts ready for release and wishes to update the market that its audited annual accounts are now expected to be released in mid-November 2026, rather than in the second half of October 2026 as previously announced.
Trading in the Company's shares remains suspended pending publication of the audited annual accounts, at which point the Company will seek restoration of trading, and will provide further updates as appropriate.
Contacts
|
Cardiogeni PLC |
|
|
Dr Darrin M Disley, Executive Chairman Ajan Reginald, Executive Officer |
Via First Sentinel |
|
First Sentinel Corporate Finance Limited, Corporate Adviser |
|
|
Brian Stockbridge Gabrielle Cordeiro |
+44 020 3855 5551 |
|
SP Angel Corporate Finance LLP, Corporate Broker |
|
|
David Hignell Vadim Alexandre Devik Mehta |
+44 20 3470 0470 |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
